| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/17/2009 | US20090311696 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 12/17/2009 | US20090311281 Novel method for down-regulation of amyloid |
| 12/17/2009 | US20090311263 Human vascular ibp-like growth factor |
| 12/17/2009 | US20090311226 Composition and method for treating esophageal dysplasia |
| 12/17/2009 | US20090311225 Compositions of and Methods of Using Stabilized PSMA Dimers |
| 12/16/2009 | EP2133430A2 Design and therapeutic use of adpase enhanced apyrases |
| 12/16/2009 | EP2133097A1 Transpulmonary liposome for controlling drug arrival |
| 12/16/2009 | EP2133092A1 Oral vaccine |
| 12/16/2009 | EP2132309A2 Compositions and methods for treating glycogen storage diseases |
| 12/16/2009 | EP2131868A1 Cardiac-specific progenitor cells |
| 12/16/2009 | EP2131863A1 A method of treating malignant mesothelioma |
| 12/16/2009 | EP1521832B1 Anti-fragilis antibody and uses thereof |
| 12/16/2009 | EP1434603B1 Method of treatment using ligand-immunogen conjugates |
| 12/16/2009 | EP1425028B1 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 12/16/2009 | EP1135469B1 An improved method for the production and purification of adenoviral vectors |
| 12/16/2009 | EP1114189B1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 12/16/2009 | CN101605560A A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma |
| 12/16/2009 | CN101603042A RNA interference target for treating hepatitis B virus infection |
| 12/16/2009 | CN100569945C Oligomeric compounds for the modulation of BCL-2 |
| 12/16/2009 | CN100569298C DNA sequence of IER5-coded SiRNA, vector and application thereof |
| 12/16/2009 | CN100569297C Gene transfer-mediated angiogenesis therapy |
| 12/15/2009 | US7632980 Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems |
| 12/15/2009 | US7632823 Compositions of tRNA and uses thereof |
| 12/15/2009 | US7632822 For prophylaxis and therapy of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, skin disorders, allergy, asthma or a disease caused by a pathogen |
| 12/15/2009 | US7632659 Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 12/15/2009 | US7632650 Diagnostics and therapeutic uses of topors |
| 12/15/2009 | US7632646 Tuberculosis diagnostic test |
| 12/15/2009 | US7632643 PCA3, PCA3 genes, and methods of use |
| 12/15/2009 | US7632516 Moraxella catarrhalis BASB115 polypeptides |
| 12/15/2009 | US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc |
| 12/15/2009 | US7632512 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections |
| 12/15/2009 | US7632510 Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence |
| 12/15/2009 | CA2601208C Method of preventing or treating type 1 diabetes by gene therapy with a secreted form of glutamic acid decarboxylase. |
| 12/15/2009 | CA2458837C Composition containing fine particles for carrying biologically active substance thereon or having the same carried thereon and method for preparing them |
| 12/15/2009 | CA2439872C Leporipox-based vector vaccines |
| 12/15/2009 | CA2347905C P53 antisense agent and method |
| 12/15/2009 | CA2294996C Angiotensin derivatives |
| 12/15/2009 | CA2269096C Method for in vitro preconditioning of myoblasts before transplantation |
| 12/15/2009 | CA2226833C Adenovirus vectors for gene therapy |
| 12/10/2009 | WO2009149418A2 Novel compositions for the in vivo delivery of rnai agents |
| 12/10/2009 | WO2009149318A2 Mirnas as therapeutic targets in cancer |
| 12/10/2009 | WO2009149191A2 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
| 12/10/2009 | WO2009148946A2 Cell line, system and method for optical control of secondary messengers |
| 12/10/2009 | WO2009148552A2 Methods and compositions for treating disease |
| 12/10/2009 | WO2009148137A1 Nucleic acid capable of controlling degranulation of mast cell |
| 12/10/2009 | WO2009147742A1 Sirna of human osteopontin |
| 12/10/2009 | WO2009147684A2 Compositions and methods for treatment of ear disorders |
| 12/10/2009 | WO2009146556A1 Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof |
| 12/10/2009 | WO2009120712A3 Compositions and methods for diagnosing and treating melanoma |
| 12/10/2009 | WO2009117736A3 Avian virus vaccines and uses thereof |
| 12/10/2009 | WO2009117418A3 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 12/10/2009 | WO2009114487A9 Use of sirna to achieve down regulation of an endogenous gene in combination with the use of a sense construct to achieve expression of a desired polynucleotide |
| 12/10/2009 | WO2009109996A3 Novel cationic amphiphiles with quinic acid head-groups for dna vaccination |
| 12/10/2009 | WO2009108706A3 Methods for inhibiting six 1 and eya proteins |
| 12/10/2009 | WO2009097077A9 Wound healing compositions and treatments |
| 12/10/2009 | WO2009054994A3 Use of compounds activating sirt-3 for mimicking exercise |
| 12/10/2009 | US20090306195 Fusion Proteins of Mycobacterium Tuberculosis |
| 12/10/2009 | US20090306177 Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide Modification |
| 12/10/2009 | US20090305991 33 Human Secreted Proteins |
| 12/10/2009 | US20090305411 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 12/10/2009 | US20090305398 Recombinant Double-Stranded RNA Phage, and Use of the Same |
| 12/10/2009 | US20090305344 Chimeric alphavirus replicon particles |
| 12/10/2009 | US20090305289 Screening method to identify protective substances for the treatment of neurodegenerative and/or ischaemic diseases |
| 12/10/2009 | US20090304817 Glycosylation Variants of Ricin-Like Proteins |
| 12/10/2009 | US20090304798 Methods and compositions for therapeutic use of RNA interference |
| 12/10/2009 | US20090304796 Nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle |
| 12/10/2009 | US20090304781 Master gene of arteriogenesis |
| 12/10/2009 | US20090304740 Use in HIV vaccines; HIV envelope proteins modified to expose the CD4 binding region |
| 12/10/2009 | US20090304708 Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin |
| 12/10/2009 | US20090304683 Soluble Fragments of The Sars-Cov Spike Glycoprotein |
| 12/10/2009 | US20090304663 Use of gsk-3 inhibitors for the treatment of prostate cancer |
| 12/10/2009 | US20090304651 Insulin-Like Growth Factor II (IGF-II) Binding Factors |
| 12/10/2009 | US20090304649 Methods of inducing or increasing the expression of proteoglycans such as aggrecan in cells |
| 12/10/2009 | US20090304630 Treating severe and acute viral infections |
| 12/10/2009 | US20090304625 Modulators of cardiac cell hypertrophy and hyperplasia |
| 12/10/2009 | CA2764456A1 Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof |
| 12/10/2009 | CA2726885A1 Sirna of human osteopontin |
| 12/09/2009 | EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 12/09/2009 | EP1679370B1 Method of evaluating cancerization degree |
| 12/09/2009 | EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 12/09/2009 | EP1129110B1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 12/09/2009 | EP1040198B1 Recombinant rhabdovirus containing a heterologous fusion protein |
| 12/09/2009 | CN101600460A Ultrasound microbubble mediated genes delivery system |
| 12/09/2009 | CN101600445A Dendritic cells transiently transfected with a membrane homing polypeptide and their use |
| 12/09/2009 | CN101597622A Series miRNA or shRNA expression vector regulated by tumour specificity promoter |
| 12/09/2009 | CN101597607A Small interfering RNA molecule inhibiting expression of SARS coronavirus N protein and coding gene thereof |
| 12/09/2009 | CN101597606A SiRNA sequence aiming at protein gene like TRAP-1 and application thereof |
| 12/09/2009 | CN101597338A Mannan-containing ligand and preparation method and application thereof |
| 12/09/2009 | CN101597337A Conjugate of hydroxyalkyl starch and an active agent |
| 12/09/2009 | CN101596316A Recombinant adenovirus expressing FoxMlsiRNA and application of tumor therapy and prevention thereof |
| 12/09/2009 | CN101596308A ITGB4BP and derivates thereof used for preventing and/or treating hypertrophic scar and fibrosis lesion |
| 12/09/2009 | CN100567490C RNA interference fragment and its use |
| 12/09/2009 | CN100567488C Enhancement of virus-mediated DNA transfer |
| 12/09/2009 | CN100566753C A hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 12/08/2009 | US7629441 Feline interferon-alpha proteins |
| 12/08/2009 | US7629330 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 12/08/2009 | US7629327 Chlamydia 60 Kda CRMP antigens and vaccine uses |
| 12/08/2009 | US7629326 Chromosomal modification involving the induction of double-stranded DNA cleavage and homologous recombination at the cleavage site |
| 12/08/2009 | US7629324 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation |